These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6459857)

  • 1. Aging of the erythrocyte. VI. Accelerated red cell membrane aging in Down's syndrome?
    Bartosz G; Soszyński M; Kedziora J
    Cell Biol Int Rep; 1982 Jan; 6(1):73-7. PubMed ID: 6459857
    [No Abstract]   [Full Text] [Related]  

  • 2. Erythrocyte anomalies in Down's syndrome.
    Bartosz G; Kedziora J
    Med Hypotheses; 1983 Aug; 11(4):471-7. PubMed ID: 6226851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrastructural modifications of the erythrocyte membrane in Down's syndrome.
    Kedziora J; Koter M; Bartel H; Bartosz G; Leyko W; Jeske J
    Acta Biol Med Ger; 1981; 40(4-5):423-8. PubMed ID: 6274112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Membrane-bound immunoglobulins increase during red blood cell aging.
    Magnani M; Papa S; Rossi L; Vitale M; Fornaini G; Manzoli FA
    Acta Haematol; 1988; 79(3):127-32. PubMed ID: 3128035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging of the erythrocyte. XX. Decreased red cell life span in Down's syndrome.
    Bartosz G; Kedziora J
    Cell Biol Int Rep; 1982 Dec; 6(12):1119-22. PubMed ID: 6217903
    [No Abstract]   [Full Text] [Related]  

  • 6. Erythrocyte glucose-6 phosphate dehydrogenase (G6PD) and Australia antigen hepatitis in Down's syndrome.
    Sutnick AI; Oski FA; London WT; Millman I; Blumberg BS
    Res Commun Chem Pathol Pharmacol; 1970 Jan; 1(1):3-8. PubMed ID: 4257700
    [No Abstract]   [Full Text] [Related]  

  • 7. Erythrocyte membrane changes of individuals with Down's syndrome in various stages of Alzheimer-type dementia.
    Bosman GJ; Visser FE; De Man AJ; Bartholomeus IG; De Grip WJ
    Neurobiol Aging; 1993; 14(3):223-8. PubMed ID: 8321389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Red cell aging. I. Surface charge density and sialic acid content of density-fractionated human erythrocytes.
    Seaman GV; Knox RJ; Nordt FJ; Regan DH
    Blood; 1977 Dec; 50(6):1001-11. PubMed ID: 922155
    [No Abstract]   [Full Text] [Related]  

  • 9. [Quantitative enzymic determination of galactokinase activity in the erythrocyte haemolysate of patients with Down's syndrome (author's transl)].
    Lippross S; Menne F
    Z Klin Chem Klin Biochem; 1974 Oct; 12(10):449-52. PubMed ID: 4279510
    [No Abstract]   [Full Text] [Related]  

  • 10. Erythrocyte glycohydrolases in subjects with trisomy 21: could Down's syndrome be a model of accelerated ageing?
    Massaccesi L; Corsi MM; Baquero-Herrera CJ; Licastro F; Tringali C; Venerando B; Lombardo A; Alberghino A; Goi G
    Mech Ageing Dev; 2006 Apr; 127(4):324-31. PubMed ID: 16460783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down's syndrome: permeability of the erythrocyte membrane for spin-labeled non-electrolytes.
    Koter M; Kedziora J; Bartosz G; Leyko W
    Experientia; 1982 Dec; 38(12):1447-8. PubMed ID: 6217983
    [No Abstract]   [Full Text] [Related]  

  • 12. Characterization of antibody that binds in vivo to normal human red blood cells.
    Clark MR; Sorette MP
    Adv Exp Med Biol; 1991; 307():357-65. PubMed ID: 1805598
    [No Abstract]   [Full Text] [Related]  

  • 13. [Lipid content in erythrocyte membranes in patients with Down's syndrome].
    Shvarts EI; Rezenberg OA
    Pediatriia; 1976 Nov; (11):68-70. PubMed ID: 136633
    [No Abstract]   [Full Text] [Related]  

  • 14. Monoclonal antibody-defined B cell subsets in aging humans and Down's syndrome.
    Gupta S; Zola H; Brooks DA; Bradley J; Fikrig SM; Mariano E; Quazi Q
    Gerontology; 1984; 30(6):388-92. PubMed ID: 6240431
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accumulation of altered aspartyl residues in erythrocyte proteins from patients with Down's syndrome.
    Galletti P; De Bonis ML; Sorrentino A; Raimo M; D'Angelo S; Scala I; Andria G; D'Aniello A; Ingrosso D; Zappia V
    FEBS J; 2007 Oct; 274(20):5263-77. PubMed ID: 17892495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent studies on erythrocyte enzymes in Down's syndrome: GOT isoenzymes].
    Furbetta M; Trabalza N; Cao A; Marcucci F
    Boll Soc Ital Biol Sper; 1971 Nov; 47(21):689-91. PubMed ID: 4260025
    [No Abstract]   [Full Text] [Related]  

  • 17. Cellular dehydration and immunoglobulin binding in senescent neonatal erythrocytes.
    Lane PA; Galili U; Iarocci TA; Shew RL; Mentzer WC
    Pediatr Res; 1988 Mar; 23(3):288-92. PubMed ID: 3353175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role and mechanism of hexokinase decay during reticulocyte maturation and cell aging.
    Magnani M; Rossi L; Bianchi M; Serafini G; Stocchi V
    Adv Exp Med Biol; 1991; 307():29-35. PubMed ID: 1805592
    [No Abstract]   [Full Text] [Related]  

  • 19. Abnormal degradation of erythrocyte membrane proteins in Down's syndrome.
    Gaczyńska M; Rosin J; Bartosz G; Kedziora J; Jeske J
    Hereditas; 1987; 106(1):151-3. PubMed ID: 2953697
    [No Abstract]   [Full Text] [Related]  

  • 20. [Dieresis of erythrocytes in the body after damage to their membranes].
    Kardash BE; Geĭtman IIa
    Ter Arkh; 1982; 54(8):95-7. PubMed ID: 7135252
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.